Physician profile
Jayesh V Patel
NPI 1558306688
$1,276.45
in general payments reported to CMS, 2019-2025
19 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.63 · 2020: $62.60 · 2021: $283 · 2022: $136 · 2023: $235 · 2024: $84.70 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518 · Travel and Lodging: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.77 |
| Travel and Lodging | $202.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $220.69 | 2019-2025 | Dupixent |
| Medtronic, INC. | $202.27 | 2025 | Kyphon Express II Kyphopak Tray |
| Inspire Medical Systems, INC. | $193.22 | 2021 | |
| Genzyme Corporation | $176.42 | 2022-2025 | |
| Stryker Corporation | $84.53 | 2019-2022 | |
| Acclarent, INC | $54.17 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $47.87 | 2019-2021 | |
| Integra Lifesciences Corporation | $44.10 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Takeda Pharmaceuticals U.S.A., INC. | $35.05 | 2023 | Glassia |
| Hikma Pharmaceuticals USA | $32.91 | 2023 | Ryaltris |
| Intersect Ent, INC. | $31.94 | 2019 | |
| Aerin Medical INC. | $31.50 | 2025 | |
| Lundbeck LLC | $25.12 | 2022 | |
| Glaxosmithkline, LLC. | $21.80 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.47 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.58 | 2023 | |
| Alk-Abello, INC | $13.67 | 2020 | |
| Optinose US, INC. | $13.16 | 2021 | |
| Ambu INC. | $10.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.